Published in Int J Cell Biol on September 03, 2013
Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors. Genes Chromosomes Cancer (2015) 0.83
Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer. Oncotarget (2015) 0.81
Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9. Oncotarget (2015) 0.81
Role of FET proteins in neurodegenerative disorders. RNA Biol (2016) 0.79
Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma. PLoS One (2016) 0.76
The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS. PLoS One (2015) 0.76
Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis. Nucleic Acids Res (2014) 0.76
DNA Occupancy of Polymerizing Transcription Factors: A Chemical Model of the ETS Family Factor Yan. Biophys J (2017) 0.75
Structure-function based molecular relationships in Ewing's sarcoma. Biomed Res Int (2015) 0.75
The RNA helicase A in malignant transformation. Oncotarget (2016) 0.75
The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities. Br J Cancer (2017) 0.75
Intricate Transcriptional Networks of Classical Brown and Beige Fat Cells. Front Endocrinol (Lausanne) (2015) 0.75
Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses. BMC Complement Altern Med (2017) 0.75
Interactome Analysis Reveals that Heterochromatin Protein 1γ (HP1γ) Is Associated with the DNA Damage Response Pathway. Cancer Res Treat (2015) 0.75
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 35.96
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
MicroRNA maturation: stepwise processing and subcellular localization. EMBO J (2002) 19.47
The Microprocessor complex mediates the genesis of microRNAs. Nature (2004) 17.70
Conserved structures and diversity of functions of RNA-binding proteins. Science (1994) 14.75
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell (1991) 14.23
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science (2009) 12.99
The DNA damage response: ten years after. Mol Cell (2007) 11.80
Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet (2003) 7.98
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (1992) 7.68
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature (2008) 7.18
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature (2001) 6.73
Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science (2007) 6.33
A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell (2009) 6.20
Large-scale proteomic analysis of the human spliceosome. Genome Res (2002) 5.75
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (1993) 5.69
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol (2009) 5.65
Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr Opin Cell Biol (2005) 5.14
Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol (2001) 4.64
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol (2010) 3.92
Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell (2005) 3.69
DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell (2009) 3.66
Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev (1996) 3.59
Unbalanced alternative splicing and its significance in cancer. Bioessays (2006) 3.17
Ewing's sarcoma. Lancet Oncol (2010) 2.96
Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J (1993) 2.91
A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. Genes Dev (1993) 2.83
Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet (2010) 2.75
EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet (1993) 2.72
A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A (2011) 2.68
Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene (2006) 2.57
Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet (2000) 2.53
Alternate splicing produces a novel cyclin D1 transcript. Oncogene (1995) 2.48
hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J (1996) 2.42
Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci (2010) 2.29
DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol (1994) 2.18
Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem (2000) 2.10
Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J (2000) 2.05
The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol (2008) 2.04
A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev (2010) 1.98
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain (2011) 1.76
High affinity interactions of nucleolin with G-G-paired rDNA. J Biol Chem (1999) 1.73
EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol (1998) 1.71
Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets. Annu Rev Pathol (2011) 1.70
Compositional determinants of prion formation in yeast. Mol Cell Biol (2010) 1.63
Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet (2012) 1.62
Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics (1996) 1.59
G-quartet-dependent recognition between the FMRP RGG box and RNA. RNA (2003) 1.54
A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability. Mol Cell (2010) 1.50
RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem (2007) 1.46
Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer. Proc Natl Acad Sci U S A (2008) 1.43
Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study of four fresh tumors. Cancer Genet Cytogenet (1984) 1.42
Emerging roles of BRCA1 alternative splicing. Mol Pathol (2003) 1.41
The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene (1994) 1.40
RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion (2011) 1.40
Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol (2010) 1.39
Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest (2007) 1.39
Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res (2001) 1.34
The Ewing sarcoma protein regulates DNA damage-induced alternative splicing. Mol Cell (2011) 1.33
EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J Biol Chem (2000) 1.33
Characterization of the promoter region of the human c-erbB-2 protooncogene. Proc Natl Acad Sci U S A (1987) 1.30
Advances in Ewing's sarcoma research: where are we now and what lies ahead? Cancer Res (2009) 1.29
Identification of a human protein that recognizes the 3' splice site during the second step of pre-mRNA splicing. EMBO J (1997) 1.25
Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J Biol Chem (2002) 1.21
Beyond zinc fingers: steroid hormone receptors have a novel structural motif for DNA recognition. Trends Biochem Sci (1991) 1.20
Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. Gene (1998) 1.20
The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res (2001) 1.19
Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics (1993) 1.18
Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Cancer Res (2006) 1.16
The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J Biol Chem (1998) 1.13
Multifunctional zinc finger proteins in development and disease. Ann Hum Genet (2002) 1.13
DNA repair mechanisms and gametogenesis. Reproduction (2001) 1.12
The splicing factor U1C represses EWS/FLI-mediated transactivation. J Biol Chem (2000) 1.12
Transcriptional down-regulation through nuclear exclusion of EWS methylated by PRMT1. Biochem Biophys Res Commun (2005) 1.09
The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene (1999) 1.09
A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited. Oncogene (1997) 1.07
Ewing sarcoma protein ewsr1 maintains mitotic integrity and proneural cell survival in the zebrafish embryo. PLoS One (2007) 1.06
Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence. Blood (2010) 1.04
Stimulation of Oct-4 activity by Ewing's sarcoma protein. Stem Cells (2005) 1.03
Downstream EWS/FLI1 - upstream Ewing's sarcoma. Genome Med (2010) 1.01
EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene (2001) 1.00
The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1. Oncogene (2004) 0.99
The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain. J Biol Chem (1997) 0.99
Molecular cloning and subcellular localisation of the snRNP-associated protein 69KD, a structural homologue of the proto-oncoproteins TLS and EWS with RNA and DNA-binding properties. J Mol Biol (1996) 0.98
Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism. Cancer Res (2006) 0.98
Characterization of a new brain-specific isoform of the EWS oncoprotein. Eur J Biochem (2001) 0.97
An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene. Oncogene (2001) 0.96
Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway. Cancer Res (2002) 0.96
Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity. Cell Cycle (2008) 0.93
Analysis of Ewing sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68/72 within protein-RNA complexes. J Proteome Res (2009) 0.92
FUS and TDP43 genetic variability in FTD and CBS. Neurobiol Aging (2011) 0.90
Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS. Curr Biol (1999) 0.89
TFIIIA: nine fingers--three hands? Trends Biochem Sci (1993) 0.87
Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage. Biochem J (2009) 0.85
Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein. FEBS J (2011) 0.85
RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains. Nucleic Acids Res (2005) 0.84
Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain. J Biol Chem (2000) 0.84
The EWS protein is dispensable for Ewing tumor growth. Cancer Res (2001) 0.83
Accumulation of pre-let-7g and downregulation of mature let-7g with the depletion of EWS. Biochem Biophys Res Commun (2012) 0.81